Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy

British Journal of Cancer

Volumn 94, Issue 5, 2006, Pages 731-736

  Deans, D A C ^a   Wigmore, S J ^a   Gilmour, H ^b   Tisdale, M J ^c   Fearon, K C H ^a   Ross, J A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cachexia; Inflammation; Prognosis; Real time PCR

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PROTEOLYSIS INDUCING FACTOR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; BENIGN TUMOR; CACHEXIA; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STOMACH BIOPSY; STOMACH CANCER; TRANSLATION REGULATION; TUMOR VOLUME; UPREGULATION;

AGED; BIOPSY; BLOOD PROTEINS; CACHEXIA; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 33644837056     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602989     Document Type: Article

References (21)

1. Akerblom IE, Murry LE (1998) Human cachexia associated protein Incyte Pharmaceuticals Inc., Palo Alto, CA. US patent 628413 (5,834,192)
2. Bishop CW, Bowen PE, Ritchey SJ (1981) Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 34: 2530-2539
3. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193
4. Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer IW (2001) Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 84(12): 1599-1601
5. Cariuk P, Lorite MJ, Todorov PT, Field WN, Wigmore SJ, Tisdale MJ (1997) Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer 76(5): 606-613
6. Cunningham TJ, Hodge L, Speicher D et al (1998) Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J Neurosci 18(18): 7047-7060
7. Jelliffe DB (1966) The Assessment of Nutritional Status of the Community WHO Monograph 53 Geneva: World Health Organization
8. Lorite MJ, Cariuk P, Tisdale MJ (1997) Induction of muscle protein degradation by a tumour factor. Br J Cancer 76(8): 1035-1040
9. Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ (2001) Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 85(2): 297-302
10. Monitto CL, Dong S-M, Jen J, Sidransky D (2004) Characterisation of a human homologue of proteolysis-inducing factor and its role in cancer cachexia. Clin Cancer Res 10: 5862-5869
11. Porter D, Weremowicz S, Chin K, Seth P, Keshaviah A, Lahti-Domenici J, Bae YK, Monitto CL, Merlos-Suarez A, Chan J, Hulette CM, Richardson A, Morton CC, Marks J, Duyao M, Hruban R, Gabrielson E, Gelman R, Polyak K (2003) A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci USA 100(19): 10931-10936
12. Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C (2001) Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Immunol Nat 2(12): 1133-1137
13. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85: 1457-1459
14. Sobin LH, Wittekind CH (2003) TNM Classification of Malignant Tumours, 6th edn. New York: John Wiley
15. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M (1996) Characterisation of a cachectic factor. Nature 379: 739-742
16. Todorov PT, Deacon M, Tisdale MJ (1997) Structural analysis of a tumour-produced sulfated glycoprotein capable of initiating muscle protein degradation. J Biol Chem 272(19): 12279-12288
17. Todorov PT, Field WN, Tisdale MJ (1999) Role of a proteolysis-inducing factor in cachexia induced by a human melanoma (G361). Br J Cancer 80(11): 1734-1737
18. Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace Jr D, Tisdale MJ, Vessella RL (2003) Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 105: 123-129
19. Watchorn TM, Waddell I, Dowidar N, Ross JA (2001) Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-κB and STAT3. FASEB J 15: 562-564
20. Wigmore SJ, Fearon KCH, Sangster K, Maingay JP, Garden OJ, Ross JA (2002) Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21(4): 881-886
21. Wigmore SJ, Todorov PT, Barber MD, Ross JA, Tisdale MJ, Fearon KCH (2000) Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br J Surg 87: 53-58